John Mccafferty

Co-founder And CTO at Maxion Therapeutics

No bio yet


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Maxion Therapeutics

Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.


Employees

11-50

Links